Explore every episode of the podcast The Journal of Clinical and Aesthetic Dermatology

Dive into the complete episode list for The Journal of Clinical and Aesthetic Dermatology. Each episode is cataloged with detailed descriptions, making it easy to find and explore specific topics. Keep track of all episodes from your favorite podcast and never miss a moment of insightful content.

	Title	Pub. Date	Duration
	James Del Rosso, DO: JCAD October 2025 Issue Highlights	30 Oct 2025	00:18:53
Send us a text Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the October 2025 issue of JCAD.
	David G. Cotter, MD, PhD: The Ideal Patient Candidate for Deuruxolitinib for Patients with Alopecia Areata	16 Oct 2025	00:01:45
Send us a text Dr. Cotter discusses providing rapid hair regrowth in patients with alopecia areata.
	David G. Cotter, MD, PhD: Utilizing the 31-gene Expression Profile Test in Patients with Melanoma	09 Oct 2025	00:08:53
Send us a text Dr. Cotter discusses results of an expert consensus panel of the 31-gene expression profile test for patients with Melanoma.
	James Del Rosso, DO: JCAD September 2025 Issue Highlights	24 Sep 2025	00:20:38
Send us a text Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the September 2025 issue of JCAD.
	David G. Cotter, MD, PhD: Providing Regrowth of Hair in Patients with Alopecia Areata	22 Sep 2025	00:06:33
Send us a text Dr. Cotter discusses providing effective treatment for patients with alopecia areata
	James Del Rosso, DO: JCAD August 2025 Issue Highlights	26 Aug 2025	00:19:21
Send us a text Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the August 2025 issue of JCAD.
	JCAD Dialogues and Reviews: Updates in Photoprotection and Recent Indication Expansions in Psoriasis and Rosacea	23 Jun 2025	00:08:55
Send us a text Dr. Del Rosso discusses advancements in photoprotection formulations, as well as recent FDA approvals that have expanded treatment options for rosacea and psoriasis.
	James Del Rosso, DO: JCAD June 2025 Issue Highlights	20 Jun 2025	00:16:21
Send us a text Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the June 2025 issue of JCAD.
	Extended-cut Podcast— Naiem Issa, MD, PhD, and Christopher Bunick, MD, PhD: Mechanisms of Dupilumab-associated Arthralgia in Patients with Atopic Dermatitis	27 May 2025	00:24:09
Send us a text In this extended cut from JCAD’s recent Journal Review video series, Drs. Issa and Bunick dive into the possible mechanistic explanations behind arthralgia associated with dupilumab, which was detailed in a case series by Drs. Issa and Bunick and their colleagues in the May issue of The Journal of Clinical and Aesthetic Dermatology.
	James Del Rosso, DO: JCAD May 2025 Issue Highlights	22 May 2025	00:15:01
Send us a text Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the May 2025 issue of JCAD.
	James Del Rosso, DO: JCAD April 2025 Issue Highlights	16 Apr 2025	00:17:58
Send us a text Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the April 2025 issue of JCAD.
	James Del Rosso, DO: JCAD February 2025 Issue Highlights	31 Jan 2025	00:12:20
Send us a text Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the February 2025 issue of JCAD.
	JCAD Dialogues and Reviews: Highlighting a Vitiligo Roundtable Discussion in JCAD	31 Jan 2025	00:03:24
Send us a text Dr. James Del Rosso discusses a recent supplement that reviews insights about the challenges faced by both patients and clinicians in managing vitiligo.
	JCAD Dialogues and Reviews: Considerations for Antibiotic Adverse Events	28 Jan 2025	00:07:57
Send us a text Dr. Del Rosso discusses potential adverse events that can occur when treating patients with trimethoprim-sulfamethoxazole.
	James Del Rosso, DO: JCAD January 2025 Issue Highlights	03 Jan 2025	00:10:09
Send us a text Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the January 2025 issue of JCAD.
	James Del Rosso, DO: Dermatology Year in Review 2024	17 Dec 2024	00:14:19
Send us a text Dr. Del Rosso reviews some of the most impactful research developments and drug approvals seen by the dermatology world in 2024.
	JCAD Dialogues and Reviews: Spotlight on a Newly Approved Treatment for Rosacea	21 Nov 2024	00:05:33
Send us a text Dr. Del Rosso discusses warning signs of serious adverse events related to trimethoprim-sulfamethoxazole prescribed to patients with acne.
	James Song, MD: Live from Elevate-Derm West—Why Older Immunosuppressant Agents are Still Relevant in 2024	11 Nov 2024	00:07:12
Send us a text Dr. Song provides helpful clinical tips for treating patients with methotrexate.
	James Song, MD: Live from Elevate-Derm West—New Topical and Systemic Agents for Atopic Dermatitis	11 Nov 2024	00:10:11
Send us a text Dr. Song provides an extensive overview of what’s new and emerging in atopic dermatitis treatment.
	James Del Rosso, DO: New and Exciting Indications for Bimekizumab, Nemolizumab, and Lebrikizumab	18 Oct 2024	00:07:04
Send us a text Dr. Del Rosso discusses three exciting new indications for drugs in dermatology and how these approvals will impact clinical practice.
	James Del Rosso, DO: JCAD October 2024 Issue Highlights	18 Oct 2024	00:17:34
Send us a text Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the October 2024 issue of JCAD.
	Leon Kircik, MD: Recent IL-17 Inhibitor Approval for Patients with Psoriasis	14 Nov 2023	00:00:49
Send us a text Dr. Kircik discusses a recent FDA-approval of an IL-17 inhibitor that has demonstrated to be safe and effective in patients with psoriasis.
	James Del Rosso, DO: Diagnostic Pearls for Psoriasis	17 Oct 2023	00:03:21
Send us a text Dr. Del Rosso discusses how to provide the correct treatment for the various presentations of psoriasis along with the impact psoriatic arthritis can have on these patients.
	Joel Gelfand, MD, MSCE, FAAD: Managing Cardiovascular Risk in Patients with Psoriasis	21 Sep 2023	00:03:29
Send us a text Dr. Gelfand discusses how to treat patients with psoriasis in terms of cardiovascular risk. He encourages clinicians to educate their patients about these events and the potential side effects they present.
	James Del Rosso, DO: Consulting Patients with Psoriasis on Biologic Therapy	09 Aug 2023	00:03:48
Send us a text Dr. Del Rosso discusses ways in which he’s modified his consultation style when speaking to patients with psoriasis who are about to commence treatment with a biologic.
	George Martin, MD: The Utilization of TNF Inhibitors for Psoriasis	11 Jul 2023	00:03:34
Send us a text George Martin, MD, discusses the specific role TNF inhibitors play for the treatment of psoriasis along with an important safety implication to be aware of for treating patients during pregnancy.
	James Del Rosso, DO: Identifying Appropriate Patients for TNF inhibitors	23 Jun 2023	00:04:53
Send us a text Dr. Del Rosso discusses biologic options for treating patients with psoriasis and psoriatic arthritis as well as pregnant patients.
	Linda Stein Gold, MD: Updates in Systemic Therapies for Psoriasis	09 May 2023	00:03:01
Send us a text Dr. Stein Gold discusses insights from clinical trials on new and upcoming systemic agents for psoriasis, including deucravacitinib and bimekizumab.
	George Martin, MD: The Current Role of TNF Inhibitors for Psoriasis	25 Apr 2023	00:01:51
Send us a text George Martin, MD, discusses TNF inhibitors for the treatment of psoriasis and how these classic biologic agents currently fit into the ever-expanding arsenal of drugs for psoriasis.
	Raj Chovatiya, MD, PhD: Mechanisms of Atopic Dermatitis Therapies	22 Feb 2023	00:01:58
Send us a text Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, reviews the mechanisms of action of currently available treatments for atopic dermatitis, including JAK inhibitors and biologic medications, and details how these medications work differently to reduce inflammation associated with the disease.
	Nicole Keeter, MSHS, PA-C: Incorporating Topical and Oral Treatments into Your Practice	21 Nov 2022	00:02:47
Send us a text Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alopecia areata. She discusses how utilizing these JAK inhibitors in the treatment of atopic dermatitis has shown to provide a rapid decrease in symptoms, particularly pruritus.
	Nicole Keeter, MSHS, PA-C: Focusing on Safety Consideration for the Prescription of JAK Inhibitors	27 Oct 2022	00:03:09
Send us a text After reviewing notable safety considerations for systemic and topical Janus kinase inhibitors for patients with atopic dermatitis, Nicole Keeter, PA-C, describes steps she has taken to become more comfortable prescribing these agents to her patients with AD and discusses important tips for counseling these patients on adverse events and black box warnings.
	James Del Rosso, DO: Topical Treatment for Atopic Dermatitis	20 Sep 2022	00:03:39
Send us a text Dr. James Del Rosso reviews various common treatments for atopic dermatitis, specifically topical agents that have demonstrated effectiveness for patients.
	Peter Lio, MD: The Evolution of Topical JAK Inhibitors	25 Aug 2022	00:02:59
Send us a text Peter Lio, MD, Assistant Professor of Clinical Dermatology and Pediatrics at Northwestern University’s Feinberg School of Medicine, discusses the development of JAK inhibitors over the years, and reviews the increase in reliability among both oral and topical treatments for atopic dermatitis.
	James Del Rosso, DO: The Benefits of Topical JAK Inhibitors	09 Aug 2022	00:02:35
Send us a text Dr. James Del Rosso discusses the benefits of topical JAK inhibitors over oral JAK inhibitors for the treatment of atopic dermatitis.
	Lisa Swanson, MD: Things to Consider When Starting Patients on JAK Inhibitors	23 Jun 2022	00:04:34
Send us a text Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist with Ada West Dermatology in Boise, Idaho, reviews the role that Janus kinases (JAKs) play in the inflammatory process and the benefits of inhibiting this enzyme when treating patients with atopic dermatitis. She also elaborates upon her experiences using the newly approved JAK inhibitors in her own patients. Dr. Swanson then outlines things to consider before starting patients on JAK inhibitors.
	Lisa Swanson, MD: Counseling Patients on JAK Inhibitors	03 May 2022	00:06:12
Send us a text Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist with Ada West Dermatology in Boise, Idaho, discusses how she intends to incorporate newly approved JAK inhibitors into her atopic dermatitis treatment algorithm and her strategies for patient counseling when treating with these agents.
	Doris Day, MD: The Effect of Stress on Hair Health	19 Apr 2022	00:02:32
Send us a text Dr. Day discusses the effect of stress on hair health.
	Raj Chovatiya, MD, PhD: Discussing Atopic Dermatitis Treatment Risks with Patients	08 Mar 2022	00:02:22
Send us a text Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, discusses how he addresses questions from his patients with AD regarding potential adverse events and warnings associated with treatments for AD.
	Douglas DiRuggiero, DMSc, PA-C: Safety of JAK Inhibitors for Atopic Dermatitis	21 Dec 2021	00:04:38
Send us a text Douglas DiRuggiero, DMSc, PA-C, discusses the exciting renaissance occurring in the realm of topical treatments for atopic dermatitis.
	Matt Zirwas, MD: Patient Preparatory Guidance for Topical JAK Inhibitors	21 Dec 2021	00:02:13
Send us a text Matthew Zirwas, MD, provides guidance on speaking with patients with atopic dermatitis about treating their condition with topical JAK inhibitors.
	Douglas DiRuggiero, DMSc, PA-C: An Overview of JAK Inhibitors for Atopic Dermatitis	01 Dec 2021	00:02:21
Send us a text Douglas DiRuggiero, DMSc, PA-C, discusses the mechanism of action and efficacy of topical and systemic JAK inhibitors for the treatment of atopic dermatitis.
	Matt Zirwas, MD: An Overview of Janus-kinase (JAK) inhibitors for Atopic Dermatitis	01 Dec 2021	00:02:15
Send us a text Matthew Zirwas, MD, discusses the efficacy, benefits, and safety profile of topical and systemic JAK inhibitors for the treatment of atopic dermatitis.

About Methodology Contact Support me Privacy Policy Legal Notice